Logo image of AMWL

AMERICAN WELL CORP-CLASS A (AMWL) Stock Fundamental Analysis

USA - NYSE:AMWL - US03044L2043 - Common Stock

5.39 USD
-0.21 (-3.75%)
Last: 10/22/2025, 8:15:46 PM
5.39 USD
0 (0%)
After Hours: 10/22/2025, 8:15:46 PM
Fundamental Rating

3

AMWL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. While AMWL has a great health rating, there are worries on its profitability. AMWL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AMWL has reported negative net income.
In the past year AMWL has reported a negative cash flow from operations.
AMWL had negative earnings in each of the past 5 years.
AMWL had a negative operating cash flow in each of the past 5 years.
AMWL Yearly Net Income VS EBIT VS OCF VS FCFAMWL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

AMWL has a worse Return On Assets (-32.04%) than 60.00% of its industry peers.
The Return On Equity of AMWL (-44.06%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -32.04%
ROE -44.06%
ROIC N/A
ROA(3y)-61.48%
ROA(5y)-42.59%
ROE(3y)-79.72%
ROE(5y)-54.34%
ROIC(3y)N/A
ROIC(5y)N/A
AMWL Yearly ROA, ROE, ROICAMWL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100

1.3 Margins

AMWL has a worse Gross Margin (49.44%) than 62.86% of its industry peers.
In the last couple of years the Gross Margin of AMWL has declined.
AMWL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.79%
GM growth 5Y-3.32%
AMWL Yearly Profit, Operating, Gross MarginsAMWL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

7

2. Health

2.1 Basic Checks

AMWL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AMWL has less shares outstanding
The number of shares outstanding for AMWL has been reduced compared to 5 years ago.
There is no outstanding debt for AMWL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AMWL Yearly Shares OutstandingAMWL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
AMWL Yearly Total Debt VS Total AssetsAMWL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

Based on the Altman-Z score of -6.48, we must say that AMWL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AMWL (-6.48) is worse than 91.43% of its industry peers.
There is no outstanding debt for AMWL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -6.48
ROIC/WACCN/A
WACC9.85%
AMWL Yearly LT Debt VS Equity VS FCFAMWL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 3.29 indicates that AMWL has no problem at all paying its short term obligations.
AMWL's Current ratio of 3.29 is fine compared to the rest of the industry. AMWL outperforms 68.57% of its industry peers.
A Quick Ratio of 3.27 indicates that AMWL has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.27, AMWL is doing good in the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 3.27
AMWL Yearly Current Assets VS Current LiabilitesAMWL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

AMWL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.99%, which is quite impressive.
The Revenue has been growing slightly by 5.84% in the past year.
The Revenue has been growing by 11.30% on average over the past years. This is quite good.
EPS 1Y (TTM)58.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.1%
Revenue 1Y (TTM)5.84%
Revenue growth 3Y0.21%
Revenue growth 5Y11.3%
Sales Q2Q%12.91%

3.2 Future

AMWL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.97% yearly.
AMWL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.64% yearly.
EPS Next Y55.23%
EPS Next 2Y27.23%
EPS Next 3Y20.19%
EPS Next 5Y12.97%
Revenue Next Year-0.84%
Revenue Next 2Y1.11%
Revenue Next 3Y2.87%
Revenue Next 5Y2.64%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMWL Yearly Revenue VS EstimatesAMWL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M 250M
AMWL Yearly EPS VS EstimatesAMWL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 -10 -20 -30 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMWL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMWL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMWL Price Earnings VS Forward Price EarningsAMWL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMWL Per share dataAMWL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

AMWL's earnings are expected to grow with 20.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.23%
EPS Next 3Y20.19%

More info and screens

0

5. Dividend

5.1 Amount

AMWL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN WELL CORP-CLASS A

NYSE:AMWL (10/22/2025, 8:15:46 PM)

After market: 5.39 0 (0%)

5.39

-0.21 (-3.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners40.45%
Inst Owner Change0%
Ins Owners4.21%
Ins Owner Change1.81%
Market Cap87.05M
Revenue(TTM)269.78M
Net Income(TTM)-124518000
Analysts70.67
Price Target10.05 (86.46%)
Short Float %1.3%
Short Ratio2.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.69%
Min EPS beat(2)30.19%
Max EPS beat(2)31.2%
EPS beat(4)4
Avg EPS beat(4)21.44%
Min EPS beat(4)7.21%
Max EPS beat(4)31.2%
EPS beat(8)6
Avg EPS beat(8)-4.17%
EPS beat(12)8
Avg EPS beat(12)-6.05%
EPS beat(16)11
Avg EPS beat(16)-1.57%
Revenue beat(2)2
Avg Revenue beat(2)8.78%
Min Revenue beat(2)8.64%
Max Revenue beat(2)8.93%
Revenue beat(4)3
Avg Revenue beat(4)4.18%
Min Revenue beat(4)-5.41%
Max Revenue beat(4)8.93%
Revenue beat(8)3
Avg Revenue beat(8)0.98%
Revenue beat(12)3
Avg Revenue beat(12)-0.27%
Revenue beat(16)4
Avg Revenue beat(16)-0.68%
PT rev (1m)0%
PT rev (3m)-4.17%
EPS NQ rev (1m)-1.76%
EPS NQ rev (3m)-5.94%
EPS NY rev (1m)2.74%
EPS NY rev (3m)4.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 0.31
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-8.76
EYN/A
EPS(NY)-5.34
Fwd EYN/A
FCF(TTM)-5.13
FCFYN/A
OCF(TTM)-4.68
OCFYN/A
SpS16.7
BVpS17.5
TBVpS12.29
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -32.04%
ROE -44.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.44%
FCFM N/A
ROA(3y)-61.48%
ROA(5y)-42.59%
ROE(3y)-79.72%
ROE(5y)-54.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.79%
GM growth 5Y-3.32%
F-Score6
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.99%
Cap/Sales 2.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.29
Quick Ratio 3.27
Altman-Z -6.48
F-Score6
WACC9.85%
ROIC/WACCN/A
Cap/Depr(3y)44.83%
Cap/Depr(5y)34.13%
Cap/Sales(3y)5.21%
Cap/Sales(5y)3.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.1%
EPS Next Y55.23%
EPS Next 2Y27.23%
EPS Next 3Y20.19%
EPS Next 5Y12.97%
Revenue 1Y (TTM)5.84%
Revenue growth 3Y0.21%
Revenue growth 5Y11.3%
Sales Q2Q%12.91%
Revenue Next Year-0.84%
Revenue Next 2Y1.11%
Revenue Next 3Y2.87%
Revenue Next 5Y2.64%
EBIT growth 1Y48.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year78.39%
EBIT Next 3Y25.48%
EBIT Next 5Y15.81%
FCF growth 1Y54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.43%
OCF growth 3YN/A
OCF growth 5YN/A